Sofosbuvir in Treatment of COVID 19

• Status: Recruiting
• Trial end date: 2021-08-31
• Target enrollment: 0
• Participant gender: All

Summary

Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Ribavirin; Sofosbuvir

Criteria

Inclusion Criteria:

• Covid positive patients.

Exclusion Criteria:

• Contraindication to sofosbuvir or ribavirin.